Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Patent Number RE046284
US RE046284 E1Filled DateDec 30, 2015
Priority DateJan 26, 2005
Publication Date-
Expiration DateJan 25, 2025
Inventor/ApplicantsTomohiro Emura
Akira Mita
Akira Mita
ExaminesRAILEY, JOHNNY F
Art Unit3991
Technology Center3900
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.